Canopy Growth GAAP EPS of -C$0.10 misses by C$0.07, revenue of C$81.3M misses by C$0.75M (CGC:NASDAQ)
Canopy Growth reported Q2 GAAP EPS of -C$0.10, missing estimates by C$0.07, with revenue of C$81.3M, up 21.9% Y/Y but missing by C$0.75M. Medical and adult-use cannabis revenue in Canada grew 18% and 17%, respectively.
How this was made
The 30-second read
Why it matters
The earnings miss is likely to depress the stock in the near term, with sector peers possibly feeling spillover effects.
Market read
Earnings miss for a mid‑cap cannabis stock; short‑term downside risk for CGC and potential sector drag.
What to watch
Potential cost‑saving measures or upcoming product launches not disclosed in the brief could mitigate downside.
Background
Canopy Growth reported its Q2 2026 results, showing a GAAP EPS miss and slight revenue shortfall.
Ticker impact
Q2 GAAP EPS of -C$0.10 missed expectations by C$0.07 and revenue of C$81.3M missed by C$0.75M, marking a fresh earnings miss.
downward pressure as market prices in the earnings shortfall
Both EPS and revenue fell short of consensus, a typical catalyst for a sell‑off in cannabis stocks.
Market effects
May weigh on broader Canadian cannabis sector as peers are compared to CGC's miss.
Limited to North American cannabis equities.
Low; impact confined to sector-specific investors.
Counterpoint
If the miss is already priced in, the stock could stabilize or rebound on short covering.
Key entities
- CompanyCanopy Growth Corporation
Canadian cannabis producer listed on NASDAQ (CGC).



